Evidence map›Paper›PMID 35242503›Full record

ArticlePreventive medicine reports2022

Fangjian Guo, Matthew Scholl, Erika L Fuchs, Abbey B Berenson, Yong-Fang Kuo

Abstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Assessing the Clinical Relevance ofCurrent oncology (Toronto, Ont.) · 2026
    Article
  3. Use of Family Relationships in Commercial Claims Data to Characterize Clinical Events of Patients withAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  4. Article
  5. BRCA genetic testing utilization and expenditures among privately insured adults in the United States, 2013 to 2022.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  6. Predictive Genetic Testing in the Cancer Management and Prevention.Journal of cancer science and clinical therapeutics · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fangjian GuoDepartment of Obstetrics & Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Matthew SchollSchool of Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Erika L FuchsDepartment of Obstetrics & Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Abbey B BerensonDepartment of Obstetrics & Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Yong-Fang KuoCenter for Interdisciplinary Research in Women's Health, University of Texas Medical Branch at Galveston, Galveston, TX, United States.

Funding

UTMB WOMEN'S HEALTH RESEARCH SCHOLARS PROGRAMK12HD052023 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BERENSON, ABBEY B · 2005 to 2023
$8.1M
Genetic testing in young women for cancer preventionK07CA222343 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GUO, FANGJIAN · 2018 to 2022
$632k
NCI NIH HHS K07 CA222343NICHD NIH HHS K12 HD052023
6 · The paper itself

Abstract

Since the 1990 s discovery of

Indexed as

APC, annual percentage changeBRCABRCA testingCancer preventionCDM, Clinformatics© Data MartElectronic health recordHER, Electronic Health RecordsICD–10, International Classification of Diseases, tenth editionICD–9, International Classification of Diseases, ninth editionNCCN, National Comprehensive Cancer NetworkTrendUSPSTF, US Preventive Services Task Force

Identifiers

PMID35242503
PMCPMC8866899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.